26-Apr-17 Despite India's online pharmacy market regulatory hurdles and startups like Zigy shutting down, some investors are backing select ventures as they look to disrupt the pharma retailing industry. Bengaluru-based Myra has roped in Matrix Partners and Times Internet as investors, putting in around USD7-8 mn. Myra is planning to enter Mumbai, Delhi, Hyderbad and Pune. [image: Myra]

20-Apr-17 As China develops, it struggles to deal with wrenching healthcare challenges. It produces few breakthrough innovations in medicine and healthcare technology. New investments and policy reforms, however, could transform China into one of the top R&D hubs. The Chinese government recently enacted new programs to stimulate entrepreneurship, bolster domestic research institutions, and promote innovative approaches to upgrading the healthcare system. [image: Techonomy / Shutterstock]

10-Apr-17 Korean biotech companies are drawing much interest and investment from well-known foreign investors including Bain Capital, Goldman Sachs and the state-run Chinese company Tsinghua Tongfang Group. Korea biotech firms, according to one investor "are second to none, in terms of technology but their values have been underestimated due to the small size of the domestic market.” [image: Business Korea]

10-Apr-17 DoctorOnCall debuts as Malaysia’s first online telehealth platform that connects patients with an extensive network of doctors and medical practitioners via audio or video call. DoctorOnCall.com.my has also become Malaysia’s first online prescription-based pharmacy, with average delivery times of 4-6 hours for areas within Kuala Lumpur and the Klang Valley, and 1-2 days for the rest of Malaysia. [image: Citizen Journalists Malaysia]

06-Apr-17 In Japanese companies' largest study to date, Takeda will test an experimental dengue vaccine on 20,100 children and adolescents in eight countries in Latin America. Takeda said it has completed enrollment for a 20,000-subject dengue vaccine trial, the largest clinical study in its history, signalling the global ambitions of its vaccine business. [image: ET Healthworld]